BacTech Mining Corporation
TSX VENTURE : BM

BacTech Mining Corporation

December 16, 2008 09:38 ET

BacTech Partners With University of Toronto Researchers to Advance Its Bioleaching Technology

TORONTO, CANADA--(Marketwire - Dec. 16, 2008) - BacTech Mining Corporation ("BacTech" or the "Company"), (TSX VENTURE:BM) is pleased to announce that is has begun working with University of Toronto researchers, Dr. Grant Ferris and Dr. Chris Kennedy. Dr. Ferris, a Professor in the University's Department of Geology, is also the Director of the Microbial Geochemistry Laboratory ("MGL"), with over 25 years of experience investigating the interaction of metals and bacteria. Dr. Kennedy, also a member of MGL, has 10 years' experience investigating microbial-metal interactions ranging from modern day volcanogenic massive sulphide and iron oxide deposits, to nuclear waste geological repositories, and also has experience in mining corporate finance.

Dr. Kennedy will be consulting with BacTech's Vice President of Technology and Engineering, Dr. Paul Miller, to further develop BacTech's bioleaching technology. The analytical facilities in the MGL and the Department of Geology are uniquely suited for bioleaching test work, and the partnership created here will assist BacTech in developing site specific solutions for the processing of difficult to treat ore and tailings in an environmentally responsible and economically beneficial manner. Dr. Miller stated, "This is a great step forward in enabling BacTech to progress our technology, as well as adding a greater capability when assessing environmental remediation projects such as at Cobalt, Ontario."

Microbial Geochemistry Laboratory website: http://www.geomicrobiology.ca/.

BACTECH PROFILE

BacTech has developed and patented bacterial oxidation technology for the treatment of refractory ores and concentrates to enhance the recovery of gold, silver and base metals. BacTech has successfully commissioned three bioleach plants for gold and demonstrated its technology in the selective recovery of base metals from complex sulphide concentrates in a joint project with Industrias Penoles de C.V. of Mexico that was completed in 2001. The Company's focus is the acquisition of equity positions in projects amenable to bioleaching. In June, the Company signed an agreement to acquire Yamana Gold Inc.'s 33% interest in two refractory gold deposits in Papua New Guinea. BacTech is also active in the Cobalt region of Ontario, studying the use of bioleaching as an environmental reclamation technology.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Except for statements of historical fact relating to the Company, certain information contained herein constitutes "forward-looking statements". Forward-looking statements are frequently characterized by words such as "plan," "expect," "project," "intend," "believe," "anticipate" and other similar words, or statements that certain events or conditions "may" or "will" occur.

Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. These factors include the inherent risks involved in the exploration and development of mineral properties, the uncertainties involved in interpreting drilling results and other ecological data, fluctuating metal prices, the possibility of project cost overruns or unanticipated costs and expenses, uncertainties relating to the availability and costs of financing needed in the future and other factors described in the section entitled "Risks" in the Company's Management Discussion and Analysis for the Year Ended December 31, 2007. Circumstances or management's estimates or opinions could change. The reader is cautioned not to place undue reliance on forward-looking statements.

Shares outstanding 60,107,206

The TSX Venture Exchange has not reviewed and does not accept any responsibility for the adequacy or accuracy of this release

Contact Information